Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design,
development, validation, verification and implementation of diagnostic tests were actively …

Fungal pathogens cause more than a billion human infections every year, resulting in more
than 1.6 million deaths annually. Understanding the natural history and evolutionary ecology …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been sweeping across the globe. Based on a …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Background Fungal coinfection is a recognized complication of respiratory virus infections,
increasing morbidity and mortality, but can be readily treated if diagnosed early. An …

The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …